HIF1A and renal cell carcinoma: In a retrospective study examining the prognostic prediction of HIF-1α in metastatic RCC patients, researchers found that patients with high HIF-1α expression had significantly worse survival than those with low expression (median survival: 13.5 versus 24.4 months, respectively) [88].